Results 121 to 130 of about 5,420,950 (275)

Medication Utilization Among Children With Sickle Cell Disease in the United States

open access: yesPediatric Blood &Cancer, Volume 72, Issue 8, August 2025.
ABSTRACT Background and Objective The medication management of children with sickle cell disease (SCD), especially since the release of the 2014 National Heart, Lung, and Blood Institute (NHLBI) SCD treatment guidelines, is not well described in the published literature.
Abiodun John Ologunowa   +5 more
wiley   +1 more source

Incidental Identification of Potentially Affected Individuals Through Expanded Carrier Screening During Preconception or Early Pregnancy

open access: yesPrenatal Diagnosis, Volume 45, Issue 9, Page 1151-1159, August 2025.
ABSTRACT Objective Expanded carrier screening (ECS) is used to assess the reproductive probability of having an offspring affected by an autosomal recessive or X‐linked recessive genetic disorder. Rarely, a presumably healthy individual may be identified to carry variants that could influence their health.
Yan Lü   +9 more
wiley   +1 more source

The Diagnostic Performance of a Sysmex XN‐31 Automated Malaria Analyzer vs. Expert Microscopy

open access: yesInternational Journal of Laboratory Hematology, Volume 47, Issue 4, Page 613-621, August 2025.
ABSTRACT Introduction Malaria is a common and life‐threatening infection. Malaria diagnosis needs to be fast and reliable. Although malaria microscopy is currently the gold standard, it is laborious, requires extensive training, and relies heavily on the proficiency of microscopists.
S. Onsongo   +9 more
wiley   +1 more source

Electrocardiographic changes among beta-thalassemic major patients in ibn al-baladi thalassemia center-Baghdad

open access: yesمجله كليه طب الكندي, 2013
Background :Thalassemia is an autosomal disease of the haemoglobin. Two types of thalassemia are recognized: thalassemia major and thalassemia intermedia.
Suhad Jassim Mohammed   +2 more
doaj  

Thalassemia Major

open access: yesHematology/Oncology and Stem Cell Therapy, 2017
Thalassemia is the most common monogenic hematologic disease that affects millions in the world and kills thousands of patients every year. Without transfusion or transplantation, patients with thalassemia major are expected to die within months of diagnosis.
openaire   +3 more sources

Prediction of cardiac complications for thalassemia major in the widespread cardiac magnetic resonance era: a prospective multicentre study by a multi-parametric approach

open access: yesEuropean Heart Journal-Cardiovascular Imaging, 2018
A. Pepe   +19 more
semanticscholar   +1 more source

A rare mutation [IVS-I-130 (G-A)] in a Turkish β-thalassemia major patient [PDF]

open access: bronze, 2000
Ghazi Omar Tadmouri   +5 more
openalex   +1 more source

Sonographic Findings in Fetal Alpha Thalassemia Major [PDF]

open access: bronze, 2001
Mariana Kozirovsky, Julia Shvetsova
openalex   +1 more source

Home - About - Disclaimer - Privacy